J.M. Hartwell’s Pacira BioSciences PCRX Stock Holding History

J.M. Hartwell’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,500	Closed	-$755K	–	112
2015 Q1	$755K	Buy	+8,500	New	+$862K	0.16%	38

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

J.M. Hartwell's PCRX Position: Q2 2015 in Review

J.M. Hartwell sold out of Pacira BioSciences (PCRX) in Q2 2015, closing a stake of 8,500 shares — an estimated $755K sold.

J.M. Hartwell first reported a position in PCRX in Q1 2015 and held it in 1 quarter. The position peaked at $755K in Q1 2015. 187 funds tracked by Wall St. Rank hold PCRX as of Q2 2015.

J.M. Hartwell reported no remaining Pacira BioSciences position as of Q2 2015 after selling out during the quarter.
J.M. Hartwell sold 8,500 Pacira BioSciences shares in Q2 2015, an estimated $755K.
J.M. Hartwell first reported a position in Pacira BioSciences in Q1 2015 and held it in 1 quarter.
J.M. Hartwell's Pacira BioSciences position peaked at $755K in Q1 2015.
187 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2015.

Based on J.M. Hartwell's 13F filing for Q2 2015, filed 7 Jul 2015.